Dogwood Therapeutics DWTX Offering Costs Included In Accounts Payable And Accrued Expenses
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept dwtx:OfferingCostsIncludedInAccountsPayableAndAccruedExpenses.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's offering costs included in accounts payable and accrued expenses.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's offering costs included in accounts payable and accrued expenses?
- Dogwood Therapeutics (DWTX) reported offering costs included in accounts payable and accrued expenses of $119.59K in Q1 2025.